tiprankstipranks
pc:epibi

EpiBiologics

1900 Alameda de Las Pulgas San Mateo, California 94402, US
https://www.epibiologics.com/
EpiBiologics is a biotech company developing tissue-selective extracellular protein degradation therapeutics using a proprietary modular bispecific antibody platform (EpiTAC). The company focuses on targeted degradation of disease-driving membrane and soluble proteins to create novel therapies in oncology and immunology.

Leadership & Board

Current Number of Employees50
Current LinkedIn Followers5,374

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$107M
Total Amount Raised$107M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$107M
Latest Funding Amount$107M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

EpiBiologics had 50 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
50Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

EpiBiologics had 5,374 followers as of September 7, 2026. The number of followers increased by 7 (0.13%) week-over-week.
5,374Latest Followers Count
7(0.13%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series B
$107.00M

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to EpiBiologics, helping you discover and navigate related company profiles.

Related News and Analysis